August 10, 2024Open Access

Severe intraocular inflammation after intravitreal injection of faricimab: a single-site case series of six patients

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

To describe the patient characteristics and clinical course of severe intraocular inflammation (IOI) following intravitreal injection (IVT) of faricimab.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Ghezala et al. (Sat,) studied this question.

synapsesocial.com/papers/68e5cb6fb6db64358756255e https://doi.org/https://doi.org/10.1016/j.ajo.2024.08.008

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Intra-Ocular Inflammation and Occlusive Retinal Vasculitis Following Intravitreal Injections of Faricimab: A Case Report2024 · 23 citations
2Association of Occlusive Retinal Vasculitis With Intravitreal Faricimab2024 · 31 citations
3HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration2019 · 921 citations
4Endophthalmitis2013 · 502 citations
5Study of stability and biophysical characterization of ranibizumab and aflibercept2016 · 44 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo